1.1                          A bill for an act 
  1.2             relating to health; increasing the fee to include a 
  1.3             confirmatory testing and a follow-up system to track 
  1.4             infants with inborn metabolic diseases; amending 
  1.5             Minnesota Statutes 1994, section 144.125.  
  1.6   BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: 
  1.7      Section 1.  Minnesota Statutes 1994, section 144.125, is 
  1.8   amended to read: 
  1.9      144.125 [TESTS OF INFANTS FOR INBORN METABOLIC ERRORS.] 
  1.10     It is the duty of (1) the administrative officer or other 
  1.11  person in charge of each institution caring for infants 28 days 
  1.12  or less of age and (2) the person required in pursuance of the 
  1.13  provisions of section 144.215, to register the birth of a child, 
  1.14  to cause to have administered to every infant or child in its 
  1.15  care tests for hemoglobinopathy, phenylketonuria, and other 
  1.16  inborn errors of metabolism in accordance with rules prescribed 
  1.17  by the state commissioner of health.  In determining which tests 
  1.18  must be administered, the commissioner shall take into 
  1.19  consideration the adequacy of laboratory methods to detect the 
  1.20  inborn metabolic error, the ability to treat or prevent medical 
  1.21  conditions caused by the inborn metabolic error, and the 
  1.22  severity of the medical conditions caused by the inborn 
  1.23  metabolic error.  Testing and the recording and reporting of the 
  1.24  results of the tests shall be performed at the times and in the 
  1.25  manner prescribed by the commissioner of health.  The 
  2.1   commissioner shall charge laboratory service fees a fee of $15 
  2.2   for conducting the screening and confirmatory tests of and for 
  2.3   implementing and maintaining a system to follow up infants for 
  2.4   with inborn metabolic errors so that the total of fees collected 
  2.5   will approximate the costs of conducting the tests and 
  2.6   maintaining the infant tracking system.  Costs associated with 
  2.7   capital expenditures and the development of new procedures may 
  2.8   be prorated over a three-year period when calculating the amount 
  2.9   of the fees.